RxDoctor Payments Data

Nathan Christenson, NP

Adult Health · St Louis Park, MNNPI 1851608178

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Medtronic at 43.4% of the total. 2025 is the largest year on record at $625, more than ten times the $44 reported in 2022.

$1,068in general payments, 2019–2025

Across 27 payments — averaging $39.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$464
  • Boehringer Ingelheim$179
  • Novartis$99
  • Abbott$88
  • Hologic Sales And Service, LLC$68
  • E.r. Squibb & Sons, L.L.C.$40
  • plus $131 from 6 others

What the payments were for

  • Travel & lodging$44642%
  • Food & beverage$62358%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,068 in reported general payments places this provider in the 85th percentile of 233 adult health providers in Minnesota.

See all adult health providers in Minnesota

Medicare billing

Part B allowed, 2024
$28,728
Medicare patients
369
Services billed
569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$52,788
BrilintaTicagrelor26$21,042
Repatha SureclickEvolocumab16$13,828
Metoprolol Succinate68$875
Hydralazine Hcl28$507
Atorvastatin Calcium50$473
Lisinopril36$431
Carvedilol38$391
Torsemide17$264
Nitroglycerin23$228
Amlodipine Besylate41$208
Isosorbide Mononitrate ErIsosorbide Mononitrate19$179
ClopidogrelClopidogrel Bisulfate19$167
Furosemide40$121
Losartan Potassium13$45

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$22$21,04226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 233 adult health providers in Minnesota.

Other adult health in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →